| |
Name
|
Size
|
Creator |
Creation Date
|
Labels |
|
|
|
Microsoft Powerpoint Presentation
Clinical Scale Scores20210224.pptx
|
12.14 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
12.14 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Powerpoint Presentation
Contact dermatitis 2.pptx
|
6.13 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
6.13 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Powerpoint Presentation
Disorder associations additional considerations.pptx
|
6.07 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
6.07 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Powerpoint Presentation
Contact dermatitis.pptx
|
5.88 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
5.88 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Word Document
Migration of Evaluation Procedures to Observables Inception-Elaboration.docx
|
5.59 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
5.59 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Powerpoint Presentation
Exacerbation.pptx
|
5.40 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
5.40 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Powerpoint Presentation
Concept inactivation EAG 20210224.pptx
|
4.21 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
4.21 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Powerpoint Presentation
Contact dermatitis 2 (1).pptx
|
4.10 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
4.10 MB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Powerpoint Presentation
Concept Inactivation Summary EAG 20210324v 0.3.pptx
|
3.88 MB |
Paul Amos |
2021-Mar-24, 19:03 |
|
|
| |
Version 2 (current)
|
3.88 MB |
Paul Amos |
2021-Mar-24, 19:03 |
|
|
| |
Version 1
|
3.88 MB |
Paul Amos |
2021-Mar-24, 17:28 |
|
|
|
|
Microsoft Powerpoint Presentation
Sequela additional testing final 2.pptx
|
995 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
995 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Powerpoint Presentation
EAG - Poisoning and Overdose.pptx
|
610 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
610 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
PDF File
EAG - Product role - Briefing note March 2021.pdf
|
597 kB |
Farzaneh Ashrafi |
2021-Mar-18, 20:48 |
|
|
| |
Version 1 (current)
|
597 kB |
Farzaneh Ashrafi |
2021-Mar-18, 20:48 |
|
|
|
|
PDF File
Concept Inactivation - Proposed Amendments v0.5.pdf
|
393 kB |
Jim Case |
2021-Mar-24, 13:39 |
|
|
| |
Version 2 (current)
|
393 kB |
Jim Case |
2021-Mar-24, 13:39 |
|
|
| |
Version 1
|
393 kB |
Jim Case |
2021-Mar-24, 13:38 |
|
|
|
|
PDF File
EAG - Product role - Briefing note March 2021 (1).pdf
|
382 kB |
Farzaneh Ashrafi |
2021-Mar-24, 14:15 |
|
|
| |
Version 1 (current)
|
382 kB |
Farzaneh Ashrafi |
2021-Mar-24, 14:15 |
|
|
|
|
Microsoft Excel Spreadsheet
Imapct of retiring Sequela (disorder).xlsx
|
70 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
70 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
Microsoft Excel Spreadsheet
Impact of retiring Sequela (disorder).xlsx
|
70 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
70 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
|
|
PNG File
image2020-9-23_7-13-33.png
|
51 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
| |
Version 1 (current)
|
51 kB |
Jim Case |
2021-Mar-08, 16:08 |
|
|
